FALP-UIDO ( Site 2400)

Santiago, Region M. de Santiago 7500921

0 studies enrolling now · 2 studies all time

What they study most

DLBCL, Diffuse Large B-Cell Lymphoma, Melanoma

Studies at this site

• A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003) — Recruiting now
• A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001) — Running, not enrolling